Arjun Balar
MD
Associate Professor of Medicine
👥Biography 个人简介
Arjun Balar led the pivotal atezolizumab and pembrolizumab trials in cisplatin-ineligible locally advanced or metastatic bladder cancer, contributing to the first immunotherapy approvals in this setting. His research on biomarkers of response including PD-L1 expression and TMB in bladder cancer has helped define patient selection criteria. He continues to lead investigator-initiated and cooperative group studies in urothelial carcinoma.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-02-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Arjun Balar 的研究动态
Follow Arjun Balar's research updates
留下邮箱，当我们发布与 Arjun Balar（NYU Langone Perlmutter Cancer Center）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment